- Home
- PLUR vs ZGM Comparison
PLUR vs ZGM Comparison
Compare PLUR & ZGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLUR | ZGM |
|---|---|---|
| Founded | 2001 | 2019 |
| Country | Israel | Macau |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 30.0M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | PLUR | ZGM |
|---|---|---|
| Price | $2.96 | $2.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 48.9K | 25.0K |
| Earning Date | 02-10-2026 | 02-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 401.52 |
| EPS | N/A | ★ 0.17 |
| Revenue | $1,326,000.00 | ★ $3,620,780.00 |
| Revenue This Year | $97.38 | N/A |
| Revenue Next Year | $293.97 | N/A |
| P/E Ratio | ★ N/A | $12.01 |
| Revenue Growth | 121.74 | ★ 211.78 |
| 52 Week Low | $2.82 | $1.90 |
| 52 Week High | $7.13 | $4.51 |
Technical Indicators
Market Signals| Indicator | PLUR | ZGM |
|---|---|---|
| Relative Strength Index (RSI) | 39.69 | N/A |
| Support Level | $2.90 | N/A |
| Resistance Level | $3.42 | N/A |
| Average True Range (ATR) | 0.28 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 17.58 | 0.00 |
Price Performance
Historical ComparisonAbout PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About ZGM Zenta Group Company Limited Ordinary Shares
Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.